Methylprednisolone in adults hospitalized with COVID-19 pneumoniaAn open-label randomized trial (GLUCOCOVID)

被引：0

作者：

Luis Corral-Gudino

Alberto Bahamonde

Francisco Arnaiz-Revillas

Julia Gómez-Barquero

Jesica Abadía-Otero

Carmen García-Ibarbia

Víctor Mora

Ana Cerezo-Hernández

José L. Hernández

Graciela López-Muñíz

Fernando Hernández-Blanco

Jose M. Cifrián

Jose M. Olmos

Miguel Carrascosa

Luis Nieto

María Carmen Fariñas

José A. Riancho

机构：

[1] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna

[2] Hospital Bierzo,Servicio de Medicina Interna

[3] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Enfermedades Infecciosas

[4] Universidad de Valladolid,Hospital Rio Hortega, Servicio de Medicina Interna, Consulta de Enfermedades Infecciosas

[5] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Medicina Interna

[6] Universidad de Cantabria,IDIVAL, Hospital U M Valdecilla, Servicio de Neumología

[7] Hospital Universitario Río Hortega,Servicio de Neumología

[8] Hospital Laredo,Servicio de Medicina Interna

[9] Hospital Sierrallana,Servicio de Medicina Interna

来源：

Wiener klinische Wochenschrift | 2021年 / 133卷

关键词：

Glucocorticoids; SARS-CoV-2; Mortality; Coronavirus Infections; Humans;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：303 / 311

页数：8

共 50 条

[41] A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
Harandi, Ali Amini
Pakdaman, Hossein
Medghalchi, Aida
Kimia, Negin
Kazemian, Alireza
Siavoshi, Fatemeh
Barough, Siavash Shirzadeh
Esfandani, Akram
Hosseini, Mohammad Hossein
Sobhanian, Seyed Ali
SCIENTIFIC REPORTS, 2024, 14 (01)
[42] A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
Ali Amini Harandi
Hossein Pakdaman
Aida Medghalchi
Negin Kimia
Alireza Kazemian
Fatemeh Siavoshi
Siavash Shirzadeh Barough
Akram Esfandani
Mohammad Hossein Hosseini
Seyed Ali Sobhanian
Scientific Reports, 14
[43] Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial
Sekhavati, Ehsan
Jafari, Fatemeh
SeyedAlinaghi, SeyedAhmad
Jamalimoghadamsiahkali, Saeidreza
Sadr, Sara
Tabarestani, Mohammad
Pirhayati, Mohammad
Zendehdel, Abolfazl
Manafi, Navid
Hajiabdolbaghi, Mahboubeh
Ahmadinejad, Zahra
Kouchak, Hamid Emadi
Jafari, Sirous
Khalili, Hosein
Salehi, Mohamadreza
Seifi, Arash
Golestan, Fereshteh Shahmari
Ghiasvand, Fereshteh
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (04)
[44] Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial
Rastvorceva, Rada M. Grubovic
Useini, Sedula
Stevanovic, Milena
Demiri, Ilir
Petkovic, Elena
Franchini, Massimo
Focosi, Daniele
LIFE-BASEL, 2022, 12 (10):
[45] Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled Trial
Les, Inigo
Loureiro-Amigo, Jose
Capdevila, Ferran
Oriol, Isabel
Elejalde, Inaki
Aranda-Lobo, Judit
Modesto, Joao
Guell-Farre, Elena
Garcia, Ruth
Murgadella-Sancho, Anna
Anniccherico, Javier
Martin-Fernandez, Miguel
Lorza, Jose Javier
Monteys-Montblanch, Joan-Pol
Librero, Julian
Pintado-Lalueza, Sara
Delgado, Marina
Gracia-Garcia, Berta
Sanchez-Alvarez, Julio
Pestana-Fernandez, Melani
Fanlo, Patricia
Funalleras-Puig, Gisela
Sarobe, Maite
Mediavilla, Eduardo
Ibero, Carlos
FRONTIERS IN MEDICINE, 2022, 9
[46] RETRACTION: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, Philippe
Lagier, Jean-Christophe
Parola, Philippe
Hoang, Van Thuan
Meddeb, Line
Mailhe, Morgane
Doudier, Barbara
Courjon, Johan
Giordanengo, Valerie
Vieira, Vera Esteves
Dupont, Herve Tissot
Honore, Stephane
Colson, Philippe
Chabriere, Eric
La Scola, Bernard
Rolain, Jean-Marc
Brouqui, Philippe
Raoult, Didier
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2025, 65 (01)
[47] Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
Song, Joon-Young
Yoon, Jin-Gu
Seo, Yu-Bin
Lee, Jacob
Eom, Joong-Sik
Lee, Jin-Soo
Choi, Won-Suk
Lee, Eun-Young
Choi, Young-Ah
Hyun, Hak-Jun
Seong, Hye
Noh, Ji-Yun
Cheong, Hee-Jin
Kim, Woo-Joo
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
[48] Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial
Zhang, Xin-Yi
Lv, Lang
Zhou, Yu-Long
Xie, Liang-Dong
Xu, Qin
Zou, Xiao-Fan
Ding, Yan
Tian, Jie
Fan, Jia-Liang
Fan, Hai-Wei
Yang, Yi-Xi
Ye, Xiao-Qun
PHYTOTHERAPY RESEARCH, 2021, 35 (08) : 4401 - 4410
[49] A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial
Laikitmongkhon, Jakkrit
Tassaneyasin, Tanapat
Sutherasan, Yuda
Phuphuakrat, Angsana
Srichatrapimuk, Sirawat
Petnak, Tananchai
Eksombatchai, Dararat
Thammavaranucupt, Kanin
Sungkanuparph, Somnuek
BMC PULMONARY MEDICINE, 2024, 24 (01):
[50] Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial
Corral-Gudino, Luis
Cuascovich, Ivan
Ignacio Martin-Gonzalez, Jose
Muela-Molinero, Alberto
Abadia-Otero, Jesica
Gonzalez-Fuentes, Roberto
Ruiz-de-Temino, Angela
Tapia-Moral, Elena
Cuadrado-Medina, Francisca
Martin-Asenjo, Miguel
Miramontes-Gonzalez, Pablo
Luis Delgado-Gonzalez, Jose
Ines, Sandra
Abad-Manteca, Laura
Usategui-Martin, Iciar
Ruiz-Albi, Tomas
Miranda-Riano, Sara
Rodriguez-Forunez, Patricia
Rodriguez-Jimenez, Consuelo
Lopez-Franco, Esperanza
Marcos, Miguel
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (01)

← 1 2 3 4 5 →